Search results
Results From The WOW.Com Content Network
LONDON -- Smith & Nephew (ISE: SN.L) pleased the market today by announcing a 50% increase to the interim dividend and a new progressive dividend policy that could significantly improve the shares ...
Shares in the firm, which makes orthopaedic implants and prosthetics, wound dressings, and other surgical technologies, were up 3.7% at 10 UK's Smith+Nephew retains forecast for 5-6% revenue ...
LONDON -- Shares in Smith & Nephew have risen steadily in recent months, and were recently up 11% in the year to date. And I believe that the company's concerted drive toward higher-growth areas ...
Smith & Nephew plc, also known as Smith+Nephew, is a British multinational medical equipment manufacturing company headquartered in Watford, England. [7] It is an international producer of advanced wound management products, arthroscopy products, trauma and clinical therapy products, and orthopaedic reconstruction products. [ 8 ]
The S&P 500 Dividend Aristocrats is a stock market index composed of the companies in the S&P 500 index that have increased their dividends in each of the past 25 consecutive years. It was launched in May 2005. [ 1]
LONDON -- I'm always searching for shares that can help ordinary investors like you make money from the stock market. Right now I am trawling through the FTSE 100 and giving my verdict on every ...
Bohuon was the chief executive of Smith & Nephew plc and Smith & Nephew Inc from April 2011 until May 2018. [4] He was the chief executive of Laboratoires Pierre Fabre from September 2010. Before that, he worked for Abbott Laboratories from 2003 to July 2010, rising to executive vice president, pharmaceutical products. [citation needed]
LONDON -- Smith & Nephew this morning filed results for the full year to Dec. 31, 2012. Reported revenue was down over 3% at $4,135 million, and trading profit barely rose, up less than 0.5% to ...